These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2620330)

  • 1. [Monitoring the effectiveness of amiodarone in the treatment of ventricular ectopic arrhythmias].
    Pleskot M; Pidrman V; Tilser P
    Cas Lek Cesk; 1989 Nov; 128(45):1417-20. PubMed ID: 2620330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
    Pleskot M; Pidrman V; Tilser P; Parízek P
    Vnitr Lek; 1995 Sep; 41(9):581-5. PubMed ID: 7483346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Programmed ventricular stimulation in the evaluation of the clinical significance of premature ventricular contractions].
    Pleskot M; Pidrman V; Tilser P; Pospísil M; Strasová A; Pilc M; Rehor P
    Vnitr Lek; 1991 Jun; 37(6):548-56. PubMed ID: 1716804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late ventricular potentials--relation to the results of programmed ventricular stimulation, the incidence of ventricular ectopic arrhythmias and left ventricular function].
    Pleskot M; Tilser P; Pidrman V; Plic M; Pospísil M; Cernohorský D; Strasová A
    Vnitr Lek; 1992 Jun; 38(6):555-61. PubMed ID: 1529560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral amiodarone in high-risk ventricular arrhythmias.
    Toruncha A; García-Barreto D; González-Gómez A; Llerena L; Sellén J; Ramos-Emperador C; Cabrera-Alonso C; Hernández-Cañero A
    Cor Vasa; 1982; 24(5):354-64. PubMed ID: 7172689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmic syncope and invasive electrophysiologic heart function tests].
    Pleskot M; Pidrman V; Tilser P; Pilc M; Pospísil M; Strasová A
    Vnitr Lek; 1991 May; 37(5):425-34. PubMed ID: 1842139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL; Lechat P; Frank R; Lascault G; Fontaine G; Facquet J; Cohen A; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1984; 33(5):309-15. PubMed ID: 6476769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Revascularization of the myocardium and electrical instability of the ventricles].
    Pleskot M; Parízek P; Hodac M; Haman L; St'ásek J; Cervinka P; Tauchman M
    Vnitr Lek; 1999 Feb; 45(2):75-80. PubMed ID: 15641224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic importance of invasive electrophysiologic findings in the heart].
    Pleskot M; Pidrman V; Tilser P; Parízek P; Ettlerová E
    Vnitr Lek; 1995 May; 41(5):291-7. PubMed ID: 7653057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E; Ferroni C; Marini M; Campanari G
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F; Santarelli P; Montenero S; Nobile A; Spampinato A; Nava S; Zecchi P; Manzoli U
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
    Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
    Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias.
    Anastasiou-Nana M; Levis GM; Moulopoulos SD
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):229-35. PubMed ID: 6746145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ventricular fibrillation in chronic heart disease].
    Pleskot M; Parízek P; Hodac M; Haman L; Stásek J; Cervinka P; Tauchman M
    Vnitr Lek; 2000 Feb; 46(2):80-6. PubMed ID: 11048528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.